End-payors reach $54 million settlement in Aggrenox antitrust case
MLex Summary: End-payor plaintiffs have asked US District Judge Stefan R. Underhill to grant preliminary approval to their $54 million settlement with Boehringer Ingelheim, Barr Pharmaceuticals, and Teva Pharmaceuticals in a...To view the full article, register now.
Already a subscriber? Click here to view full article